Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Attendo ABCHIX:ATTS 68 EV-to-EBIT is 16.76 as of Jul. 29, 2026, which is 20% below its 10-year median of 20.82. GuruFocus rates CHIX:ATTS with a GF Score™ of 68/100 and a GF Value™ of kr58.56 (Significantly Overvalued). The stock has 10 warning signs investors should review. Among 471 Healthcare Providers & Services companies, Attendo AB ranks worse than 53.93% on this metric.
The historical rank and industry rank for Attendo AB's EV-to-EBIT or its related term are showing as below:
CHIX:ATTs'
s EV-to-EBIT Range Over the Past 10 Years
Min: -68.92 Med: 20.82 Max: 34.02
Current: 16.76
During the past 13 years, the highest EV-to-EBIT of Attendo AB was 34.02. The lowest was -68.92. And the median was 20.82.
CHIX:ATTs's EV-to-EBIT is ranked worse than 53.93% of 471
companies
in the Healthcare Providers & Services industry
Industry Median: 15.74
vs CHIX:ATTs: 16.76
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Attendo AB's Enterprise Value for the quarter that ended in Mar. 2026 was kr29,346 Mil.
Attendo AB's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr1,836 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Attendo AB EV-to-EBIT Related Terms
Attendo AB EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for Attendo AB's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Attendo AB's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Attendo AB EV-to-EBIT vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Attendo AB's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Attendo AB's EV-to-EBIT falls into.
Attendo AB's current Enterprise Value is kr30,780 Mil.
Attendo AB's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr1,836 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Attendo AB (CHIX:ATTS) has a EV-to-EBIT of 16.76 as of Jul. 29, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Attendo AB and its competitors. This is 20% below median its historical median of 20.82. According to the industry distribution chart, Attendo AB ranks #254 out of 471 companies in the Healthcare Providers & Services industry, placing it in the top 53.9%.
Is Attendo AB's EV-to-EBIT too high?
Attendo AB's current EV-to-EBIT of 16.76 is 20% below median its 10-year median of 20.82. The Healthcare Providers & Services industry median EV-to-EBIT is 15.74. Attendo AB's value of 16.76 is 6.5% above this industry median. Based on the distribution chart, Attendo AB ranks #254 out of 471 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Attendo AB has a GF Score™ of 68/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Attendo AB's EV-to-EBIT compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Attendo AB ranks #254 out of 471 companies for EV-to-EBIT. This places Attendo AB in the lower half of its industry. The industry median EV-to-EBIT is 15.74. Attendo AB's value of 16.76 is 6.5% above this benchmark. While the company's 10-year median is 20.82 vs. the industry median of 15.74, Attendo AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Healthcare Providers & Services company?
The median EV-to-EBIT among Healthcare Providers & Services companies is 15.74, based on 471 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Attendo AB's current EV-to-EBIT of 16.76 is 6.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Attendo AB and its competitors. For the Healthcare Providers & Services industry, the median EV-to-EBIT is 15.74 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Attendo AB's current EV-to-EBIT is 16.76, which is 20% below median its own 10-year median of 20.82. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Attendo AB stock overvalued right now?
Based on GuruFocus' analysis, Attendo AB (CHIX:ATTS) is currently considered Significantly Overvalued. The stock's GF Value™ is kr58.56, compared to a current price of kr114.65 — trading 95.8% above its estimated fair value. The current EV-to-EBIT is 16.76, which is 20% below median its 10-year median of 20.82 and 6.5% above the Healthcare Providers & Services industry median of 15.74. Attendo AB's overall GF Score™ is 68/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Attendo AB (CHIX:ATTS), the current EV-to-EBIT is 16.76 as of Jul. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Attendo AB (CHIX:ATTS) Overvalued in 2026?
Based on GuruFocus' analysis, Attendo AB stock appears to be overvalued.
The current stock price of kr114.65 is trading 95.8% above its estimated GF Value™ of kr58.56.
GuruFocus considers Attendo AB to be Significantly Overvalued.
Key valuation signals for CHIX:ATTS:
EV-to-EBIT: 16.76 (20% below median its 10-year median of 20.82)
GF Value™: kr58.56 vs. price of kr114.65 (95.8% above fair value)
Industry Position: 6.5% above the Healthcare Providers & Services median (#254 of 471)
No single metric tells the full story. See the CHIX:ATTS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Attendo AB is a company that is engaged in providing private care and healthcare services in the Nordics. It focuses on offering care for older people, care for people with disabilities, individual and family care, and health care. The company also offers health, medical, and as well as staffing services. Geographically, the group's majority revenue is generated from Finland, it also operates in Scandinavia countries.
68GF Score
Get the complete analysis for CHIX:ATTS
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:ATTS has been successfully added to your 
